Legal Representation
Attorney
John P. Rynkiewicz
USPTO Deadlines
Next Deadline
16 days remaining
Notification of Non-Final Action E-Mailed
Due Date
July 30, 2025
Extension Available
Until October 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 19, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 19, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 17, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, recruiting patients for trials and proceeding through the drug protocols, collection of data and reporting same to drug companies; Computerized database management, namely, editing, evaluating and processing data for third parties; performance of clinical studies, namely, managing clinical trials and studies of pharmaceutical and biotechnology products to the order and specification of drug companies; Recruitment advertisement services, namely, recruiting patients for participation in clinical trials for the testing of drugs
Class 042
Scientific investigations for medical, drug and chemical compounds efficacy purposes; Providing medical and scientific research information in the field of drugs, compounds and clinical trials; Providing medical and scientific research, namely, conducting investigations and clinical trials for drug companies; Consulting services in the field of clinical trial investigations and research for pre-approved and post-approved compounds or drugs; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific research in the nature of conducting investigations and clinical trials for drug companies; Pharmaceutical product, investigations and clinical trials evaluation; Pharmaceutical research services; Pharmaceutical research and development
Additional Information
Design Mark
The mark consists of the words CONCIERGE and CLINICAL TRIALS with two crossed keys. The bow portions of the keys have integrated capsule designs. The lining shown in the key designs is a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
035
042
USPTO Documents
Loading USPTO documents...